Your Tisch MS Researchers will be attending this year's 2018 AAN conference in Los Angeles California on April 21st-27th. Stay tuned for planned poster board presentations out of the Tisch MSRCNY lab! For more information on this year's conference, you can visit their website .
The Lancet recently published an article demonstrating the efficacy of a new MS medication, Siponimod, in secondary progressive MS patients. Siponimod is very similar to a currently available medication, called fingolimod or gilenya, but may have a better safety profile. The results of the study...
“Patients need the human connection, which physicians often overlook or discount. That connection matters. Too many doctors have decided to focus only on the science of medicine, losing sight of the art of being a healer. They can be detached from its human consequences. Sadiq’s patients are so...
Tisch MSRCNY will be closing at 2 pm today and will reopen at 9 am Tuesday, May 29th, to observe Memorial Day Weekend! We wish everyone a safe and happy holiday!
Are you signed up for any summertime 5ks, mud runs, marathons, half marathons, or cycling events? Come check out Team Tisch MS and how you can support your MS community while participating in your chosen race! Find out more here!
May 30th is World MS Day and today the global MS community comes together to raise awareness for MS research and treatment. Help us to discover the cause so that we may develop the cure! Donate to support Tisch MSRCNY on our mission here: https://tischms.org/ways-donate
We are thrilled to announce, Dr. Saud A. Sadiq is a New York Magazine , Best Doctor in the field of Neurology for 2018. To view Dr. Sadiq's full bio, Click Here . To view New York Magazine's Best Doctor's list, Click Here .